Filing Details

Accession Number:
0001447348-16-000060
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-04-22 17:09:42
Reporting Period:
2010-12-01
Filing Date:
2016-04-22
Accepted Time:
2016-04-22 17:09:42
Original Submission Date:
2010-12-01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
835887 Progenics Pharmaceuticals Inc PGNX Pharmaceutical Preparations (2834) 133379479
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250313 J Paul Maddon 777 Old Saw Mill River Road
Tarrytown NY 10591
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-01 5,000 $4.90 909,891 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. This transaction was executed in multiple trades at prices ranging from $4.85 to $4.98. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This report amends the report filed on December 1, 2010 in order to correct an administrative error in the issuer's records as to the number of shares beneficially owned by the reporting person reported in Column 5 of Table I.